Beta Wealth Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Beta Wealth Group's GILD Position: Q3 2026 in Review
Beta Wealth Group increased its Gilead Sciences (GILD) stake by 10% in Q3 2026, buying an estimated $84K and bringing the position to 6,523 shares worth $972K. The position accounts for 0.36% of the portfolio, ranked #52.
Beta Wealth Group first reported a position in GILD in Q1 2022 and has held it in 18 quarters since. 1,582 funds tracked by Wall St. Rank hold GILD as of Q3 2026.
- Beta Wealth Group held 6,523 shares of Gilead Sciences worth $972K as of Q3 2026.
- Beta Wealth Group bought 599 Gilead Sciences shares in Q3 2026, an estimated $84K.
- Gilead Sciences made up 0.36% of Beta Wealth Group's portfolio in Q3 2026, its #52 holding.
- Beta Wealth Group first reported a position in Gilead Sciences in Q1 2022 and has held it in 18 quarters since.
- 1,582 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.
Based on Beta Wealth Group's 13F filing for Q3 2026, filed 10 Nov 2026.